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Cancer

THE FORMIDABLE OPPONENT

BELIEVE WALK FOUNDERS, from left, Nancy Varner, Annie Sellas and Cathy Stockton, release doves

during the cancer survivors photo at the Redlands Bowl in Redlands in October. The 10th annual
Believe Walk, presented by Stater Bros. Charities and Inland Women Fighting Cancer, is a
grassroots event that drew nearly 12,000 participants last year. Funds raised during the event were
donated to support local cancer-fighting organizations and cancer centers, including Loma Linda
University Cancer Center. Donors and sponsors have raised more than $2.5 million in the fight
against cancer since the annual event began in 2008.
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Cancer

L O M A L I N D A U N I V E R S I T Y H E A LT H I S C O M M I T T E D
T O H E L P I N G P AT I E N T S B AT T L E T H E F O R M I D A B L E
OPPONENT OF CANCER.
WHOLE PERSON CARE SUPPORTS
PATIENTS NAVIGATING OPTIONS FOR
WORLD-CLASS TREATMENT.
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From our President

To u c h e d b y c a n c e r , L I V I N G F O R A C U R E

Even though she died 25 years ago, her
passing still reminds our family that none of
us are immune.
Probably the most emotional was
our infant granddaughter Emily, born
prematurely along with her twin sister
Abigail. Emily was diagnosed with
hepatoblastoma, a cancer of the liver
associated with prematurity. She was just
six months old. Watching her go through
chemotherapy for months, followed by
surgical removal of part of her liver and then

Richard H. Hart, MD, DrPH
PRESIDENT,
LOMA LINDA UNIVERSITY HEALTH

more chemotherapy, took a toll on all of us.
THERE ARE FEW DIAGNOSES THAT STRIKE

It is always a joy to hear from Emily now,

FEAR INTO A PATIENT AND THEIR FAMILY’S

finishing 10th grade and doing well.

HEARTS LIKE CANCER.

Despite great strides

in the last few decades, there is still great
uncertainty that rides with this single word.
Few families have totally escaped the impact
of having a loved one touched by cancer.
It has touched our family three times.
First when Linda, my sister-in-law, was
diagnosed with what turned out to be
fallopian tube cancer, a diagnosis that could
now probably be cured. Watching her, and
us, gradually move from hopeful watching to
grudging reality, was a sobering transition.

4
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And then my own encounter with
prostate cancer over a decade ago brought
the disease back home again. Despite living,
eating and checking in all the right ways, my
genetics caught up with me. I am grateful to
the skillful doctors with whom I trusted my
life and future. I still look back on that period
as a wake-up call to appreciate what one has,
here and now, and use each moment to make
a difference.
This issue of Scope is committed to this
topic — what is true, what is not, and how

LOMA LINDA UNIVERSITY
CANCER CENTER
by the numbers

700+

HIGHLY SPECIALIZED DOCTORS,
RESEARCHERS AND CAREGIVERS

11

EXPERT TEAMS SPECIALIZING IN
EACH CANCER TYPE

150+

Loma Linda University Health is pushing

ONGOING CANCER CLINICAL TRIALS

these boundaries. We have a group of young
investigators exploring many new avenues

3,000+

of detection and treatment. Some may
never work, while others could be major

NEWLY DIAGNOSED PATIENTS
TREATED EVERY YEAR

breakthroughs. But what is exciting is for

1st

Loma Linda University Health to be a haven
for cancer research, a place where both

HOSPITAL-BASED PROTON TREATMENT CENTER

basic and translational research can make a
difference in the lives of thousands.
Our goal is to become a Comprehensive
Cancer Center, a designation by the National

35

YEARS AS AN ACCREDITED ACADEMIC
COMPREHENSIVE CANCER CENTER

47

LOOK GOOD FEEL BETTER EVENTS IN 2017

67

WIG FITTINGS IN 2017

Cancer Institute that signifies the best of the
best. This is a multi-year journey, requiring
both an internal commitment and the
support of donors. We are grateful for the
leadership of Mark Reeves, MD, PhD, in this
endeavor, and are committed to taking each
necessary step. Our plan is to have our new
research building provide major laboratories
to develop new cancer prevention and
treatment modalities. We will also expand
even further our clinical trials where patients

142

ATTENDANCE FOR CANCER-FIGHTING FOODS
COOKING DEMONSTRATIONS

250

WOMEN ATTENDING SEMIMONTHLY CANCER
SUPPORT GROUP IN 2017

can have the opportunity to be enrolled in the
latest cancer treatments.
Together we can beat this opponent
for good.
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S T U D Y S A Y S M E AT P R O T E I N I S
U N H E A L T H Y, B U T P R O T E I N F R O M
NUTS AND SEEDS IS HEART SMART

RESEARCHERS AT LOMA LINDA UNIVERSITY

and a university in France have found that meat
protein is associated with a sharp increased risk
of heart disease, while protein from nuts and
seeds is beneficial for the human heart.
Their study — published online in April by
the International Journal of Epidemiology —
found that people who consumed large amounts
of meat protein experienced a 60 percent
increase in cardiovascular disease (CVD), while
people who consumed large amounts of protein
from nuts and seeds experienced a 40 percent
reduction in CVD.
The study, titled “Patterns of plant and
animal protein intake are strongly associated
with cardiovascular mortality: The Adventist
Health Study-2 cohort,” was led by co-principal
investigators Gary Fraser, MB ChB, PhD, from

6

Loma Linda University, and François Mariotti,
PhD, from AgroParisTech and the Institut
National de la Recherche Agronomique, Paris,
France, along with a team of researchers from
both organizations.
The study included data from more than
81,000 participants and represents one of the
few times detailed sources of animal protein
have been examined jointly with animal fat in a
major investigation.
“While dietary fats are part of the story
in affecting risk of cardiovascular disease,
proteins may also have important, and largely
overlooked, independent effects on risk,”
Fraser said. Fraser and his colleagues have
long suspected that including nuts and seeds
in the diet protects against heart and vascular
disease, while red meats increase risk.
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Nutritionists have traditionally looked
toward what Fraser terms “bad fats” in meats
and “helpful fats” in nuts and seeds as causal
agents. “This new evidence suggests that the
full picture probably also involves the biological
effects of proteins in these foods,” he said.
Fraser said the team’s research differed
in another significant way from previous
investigations. While prior studies have
examined differences between animal and plant
proteins, this study did not stop at just two
categories, but chose to specify meat protein
and proteins from nuts and seeds along with
other major dietary sources. “This research is
suggesting there is more heterogeneity than
just the binary categorization of plant protein or
animal protein,” Fraser said.

PHOTO BY ANSEL OLIVER

OVER $2 MILLION RAISED
FOR LOMA LINDA UNIVERSITY
C H I L D R E N ' S H O S P I T A L AT
25TH ANNIVERSARY GALA
THE 25TH ANNIVERSARY CHILDREN’S HOSPITAL FOUNDATION GALA,
presented by Walter’s Automotive Group, was an evening to remember,
raising an unprecedented $2.36 million at the March event. The theme,
“Reflection,” celebrated the first 25 years of Loma Linda University
Children’s Hospital and highlighted its bold plans for the future.
Scott Perryman, MBA, senior vice president/administrator of Children’s
Hospital, told guests at the Riverside Convention Center the future is not
possible without their support.
“Celebrating 25 years of giving is a major milestone, and it would not
have been possible without your tireless effort on our behalf,” Perryman
told the more than 1,000 attendees. “In that time, you have raised nearly
$20 million! Every single one of those dollars has been part of giving
world-class care to the children in your community.”
Funds raised will benefit Vision 2020 – The Campaign for a Whole
Tomorrow, which supports construction of the new Children’s Hospital
tower and Loma Linda University Children’s Health – Indio, which opened
in that community in March.
Richard H. Hart, MD, DrPH, president of Loma Linda University Health,
dedicated the evening to Leonard Bailey, MD, pioneer of infant heart
transplantation; Lyn Behrens, MBBS, president emerita of Loma Linda
University Health; and John Mace, MD, chair of pediatrics when Loma
Linda University Children's Hospital (LLUCH). first opened its doors, for their
vision of a hospital just for kids. “They set the standard for excellence that
has guided the hospital to be what it is today,” Hart said.

VOL. 53, NO. 2

Physicians were not the only individuals recognized. Four awards
were presented to individuals and groups who have made significant
contributions to the lives of children.
• The Big Hearts for Little Hearts Guilds received the Shirley N.
Pettis Award.
• Tim and Carol Rochford received the Discover Lifetime
Achievement Award.
• Helen Staples-Evans, DNP, MS, RN, was recognized with the
Outstanding Clinician Award.
• Alicia Lopez was given the Hometown Hero Award. Lopez was the
living donor who donated one of her kidneys to 3-year-old Matthew
Castleberry. Castleberry, who has a twin sister, began receiving
treatment at LLU Children’s Hospital while in utero due to kidney
complications. On dialysis since birth, Castleberry received the lifesaving kidney he needed from Lopez.
After hearing the inspiring story, guests were encouraged to donate
to support the Children’s Hospital in its mission to provide quality, whole
child care to every patient. It was during this time that an anonymous
donor gave $1 million toward the Loma Linda University Children’s Health
– Indio clinic.
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Updates

LOMA LINDA UNIVERSITY CHILDREN'S
H E A L T H – I N D I O C E L E B R AT E S G R A N D
OPENING WITH RIBBON-CUTTING
C E R E M O N Y A N D K I D S H E A LT H E X P O
THE COACHELLA VALLEY COMMUNITY

Wilson, mayor of Indio, and Congressman Raul
Ruiz, MD.
"Families will now have access to critical
pediatric services right here in the east
valley, strengthening the health of our entire
community," Ruiz said. “Today is an important
milestone to realizing our shared vision for
a future where everyone has access to the
affordable care they need, when they need it.”
The clinic’s Jill and Barry Golden Pavilion
was named in recognition of the generous gift
from the Jill and Barry Golden, who were on
hand for the opening celebration.
Following the ribbon-cutting was the
inaugural All About Kids Health Expo, attended
by over 1,000 community members who enjoyed
free, healthy and fun activities.
Loma Linda University Children’s Health
– Indio officially opened its doors to the

community the following day, offering pediatric
primary care services. During the remainder of
2018, the clinic will roll out services such as
urgent care, telemedicine, dentistry and other
specialties. The nearly 13,000-square-foot
building houses 20 patient exam rooms, three
dental chairs and an X-ray room.
The clinic is also home to a bottomless
bookshelf, courtesy of Scooter Golden, to
encourage reading and literacy. Any child
who receives care at Loma Linda University
Children’s Health – Indio will be able to take a
book home.

For more information about Loma Linda
University Children’s Health – Indio, visit
its website at lomalindakids.org/indio.

PHOTO BY CHET WILLIAMS

is officially home to Loma Linda University
Children’s Health – Indio, the largest pediatric
clinic in the area. The grand opening was
celebrated with a ribbon-cutting ceremony and
the All About Kids Health Expo on March 11.
Richard H. Hart, MD, DrPH, president
of Loma Linda University Health, shared his
excitement as Loma Linda University Health
expanded its service into the Coachella Valley
to provide healthcare that is accessible and
available to those who need it most.
“We are committed to this valley. We
are committed to you,” Hart said. “We are
committed to your children and the leaders they
will become for this region.”
Nearly 400 individuals attended the
ribbon-cutting ceremony, including Michael

8
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I N T E R N AT I O N A L V E G E TA R I A N
CONGRESS HIGHLIGHTS
P L A N T- B A S E D N U T R I T I O N
LOMA LINDA UNIVERSITY HEALTH hosted
the 7th International Congress on Vegetarian
Nutrition Feb. 26-28, a three-day event exploring
the theme of plant-based foods for the health of
people, populations and the planet.
More than 700 attended, including
researchers, physicians, nutritionists and
scientists, who examined the latest findings on
lifestyle practices and vegetarian nutrition that
can be used effectively in the treatment and
prevention of chronic diseases.
Scientific presentations and panel
discussions centered around recent
advancements in basic science, epidemiology
and clinical trials in vegetarian nutrition from
around the world.
Richard H. Hart, MD, DrPH, president of
Loma Linda University Health, welcomed the
international group of attendees on opening

day. “Giving nutritional advice is as old as
the Bible itself, but as new as the latest pill.”
According to Hart, the study of optimum
nutrition isn’t novel. “Seventh-day Adventists
have been doing it for more than 150 years, and
Loma Linda University Health has been studying
the connections between food and health since
the 1950s.”
The conference, held every five years, offers
an opportunity for health professionals to learn
from each other. Over the past 30 years, the
congress has become the premier scientific
conference on the health benefits of plantbased diets.
“This scientific conference is not just about
nutrition and dietetics,” said Joan Sabaté,
MD, DrPH, director of the Center for Nutrition,
Lifestyle and Disease Prevention at Loma Linda
University School of Public Health and chair of
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For updates regarding the next
congress scheduled for 2023,
visit vegetariancongress.org.

the event. “Among other sciences, it integrates
epidemiology, environmental sciences
and education.”
In addition to the presentations, the
conference offered various interactive social
activities. These included morning runs with
university faculty and leadership; culinary
demonstrations led by Chef Cory Gheen, MS,
RDN; Nasira Burholder-Cooley, DrPH, RDN; and
Wendy Bazilian, DrPH, MA, RDN; an opening
night reception; and a banquet hosted by Loma
Linda University School of Public Health.
On Sunday, Feb. 25, the conference
hosted a special community event — Plant
Your Future — at Loma Linda University
Health – San Bernardino. The pre-conference
event featured a free cooking demonstration,
health talks, a gardening demo and free blood
pressure screenings.

9
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Updates

LOMA LINDA UNIVERSITY SCHOOL
O F P U B L I C H E A LT H T O O F F E R P H D
IN NUTRITION
LOMA LINDA UNIVERSITY SCHOOL OF
PUBLIC HEALTH will offer a PhD degree in

nutrition with an advanced research focus
on plant-based nutrition, making it the only
doctoral program in nutrition in Southern
California. The new degree program, which
will feature a research-based curriculum,
will start in fall 2018.
Sujatha Rajaram, PhD, associate
professor and program director, said the
school hosts the largest research cohort
of healthy vegetarians in the world: the
Adventist Health Studies. The studies date
back to the 1960s and contain information
on more than 96,000 subjects from the
United States and Canada.
“There are plenty of research
opportunities,” Rajaram said, adding
that multiple human intervention studies
(clinical trials) on plant foods and health

10

outcomes are underway at the school at any
given time.
The school is recognized as an
international leader in establishing and
disseminating the benefits of plant-based
nutrition — not only for the individual,
but also for the health of populations
and the planet. The school has hosted
the International Congress on Vegetarian
Nutrition for the last 30 years.
The PhD degree will supplant the
DrPH in nutrition the school has offered in
the past.
The school will continue to offer DrPH
degrees in health education, preventive
care, and health policy and leadership,
as well as a PhD in epidemiology. All the
programs have been revamped to meet
the 2016 competency requirements of the
Council on Education for Public Health.
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“The refocused curriculum and degree
offering are part of the school’s new
strategic direction,” Rajaram said.
Rajaram noted that one major difference
between the new PhD degree and the
previous DrPH in nutrition is the number
of units required for completion. Under the
new PhD degree program, students will
complete 72 units, while the DrPH required
99. The culminating activity for the PhD
program will be a research dissertation.
Students will also be required to submit
their research papers for peer-reviewed
journal publication.

Additional information about the PhD
in nutrition is available by contacting
Rajaram at srajaram@llu.edu.

IN OREGON’S ADVENTIST
S C H O O L S , R E S U LT S S P R O U T F R O M
LOMA LINDA UNIVERSITY'S
STEM PROGRAM
EDUCATIONAL LEADERS FROM THE OREGON
CONFERENCE OF SEVENTH-DAY ADVENTISTS

PHOTO BY ANSEL OLIVER

visited Loma Linda University in January to
thank executives for a group training program for
school teachers designed to enhance the delivery
of science, technology, engineering and math
(STEM) instruction, an initiative that local church
leaders say has helped stabilize enrollment
in denominational schools and boosted
instructional enthusiasm.

Nearly 800 K-12 teachers across North
America have been trained over the past seven
years through the Loma Linda University program,
called Excellence in STEM Experiential Education
(EXSEED). EXSEED enhances integrated science,
technology, engineering and math education
in Adventist K-12 schools by bringing together
teachers for one-week training sessions during
the summer.

Gale Crosby, MS, vice president of education
for the Oregon Conference, has worked closely
with Loma Linda University to challenge teachers
in the Adventist school system to help prepare
their students for careers in the medical, science
and technology fields. The impact is already
visible, even after just two years of participation,
Crosby said.
“Following our conference’s participation in
EXSEED, enrollment has stabilized in our schools,
and our churches are showing signs of growth,”
Crosby told a group of Loma Linda University
executives, deans and faculty.
Richard H. Hart, MD, DrPH, president of
Loma Linda University Health, said EXSEED is
a way to integrate the education resources of
the Adventist Church that can benefit a range
of schools, such as the two-room school he
attended in Northern Idaho as a child.
“There are still a lot of schools like that, and
they are still just as much a part of the Adventist
educational system as everyone else,” Hart
said. “We’re wanting to empower teachers to
teach STEM who may not have that strong of a
background in those subjects.”
The EXSEED program received significant
philanthropic support from Tom and Vi Zapara,
said Rachelle Bussell, MA, CFRE, Loma Linda
University Health senior vice president for
advancement. Tom Zapara was in attendance
at the January meeting. Zapara, a life-long
learner, encouraged the Oregon leadership
group and EXSEED planning group to continue
innovation and stay faithful to the mission of
Adventist education.
For more information about EXSEED,
visit home.llu.edu/exseed or
email exseed@llu.edu.
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QUESTIONS WITH
ROBERT HANDYSIDES

NEW SCHOOL OF DENTISTRY DEAN HAS YEARS OF
LEADERSHIP EXPERIENCE AND A HERITAGE OF SERVICE
BY G E N E S I S G O N Z A L E Z
When most freshmen were settling into college life, Robert Handysides, DDS, found himself adjusting to the
culture shock of returning to the United States after spending much of his childhood in Africa.
His first three months at Andrews University in Michigan required adjustments as he learned to navigate the
college system and acclimate to colder temperatures. The Michigan snow took some getting used to, even for the
Canadian native.
The son of missionaries was introduced to mission service at age 11 when he moved, along with his father, mother
and sister, first to Malawi and then to Zimbabwe, where his father served as a mission medical director. The young
man was surrounded by a different culture, opportunities for adventure and adults devoted to helping others.
“There’s a purpose in life when you’re serving others that feeds your soul and gives meaning,” Handysides says.
The sixth dean to lead Loma Linda University School of Dentistry, Handysides stepped into his new role in
January. He has spent much of his life serving in new roles and environments. “Every step of the way has been a
learning curve,” he says. In this new role, the excitement and challenge are just what he’s looking for.

WHAT HAS YOUR EXPERIENCE AT LOMA
LINDA UNIVERSITY TAUGHT YOU AS YOU
CONTINUE TO ACCEPT NEW CHALLENGES?

WHY DID YOU PURSUE A ZOOLOGY DEGREE
IN COLLEGE?

My personality is one that seeks out challenging environments.
At Loma Linda University, solutions come from a unified team, not
one individual. When you take on a different role or wear a new
hat, the support of the team is all around you. When I moved into
administration, I felt the support of the dean, Dr. Dailey, as well as
other members of the team. Now that I’ve been asked to serve as dean,
I still feel the team’s support.

12

VOL. 53, NO. 2

As a kid, I was really passionate about animals. I wasn’t a big
chemistry or physics person. I’ve always been interested in healthcare,
but zoology tended to deal with the life of animals and systems that fit
my niche of understanding biology.

WHAT INSPIRED THE MOVE FROM STUDYING
ANIMALS TO WORKING WITH TEETH?
When we were kids, my sister wanted to be a dentist and I wanted
to be a physician. We changed somewhere along life’s journey. In college,
I ended up choosing dentistry, and she chose medicine. Having a father
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who was a physician and a mom who was a nurse while growing up in
the mission field, the culture of service and healing defined our family.
This was the stimulus driving me toward healthcare.

WHAT IS YOUR FAVORITE PART ABOUT
WORKING AS A DENTIST?
When a patient comes in with an extreme amount of pain and
discomfort there is something extremely gratifying about being able to
help them in a relatively short period of time. This is something I’ve
always appreciated as an endodontist.

VOL. 53, NO. 2

WHAT ARE SOME OF YOUR TOP AREAS OF
FOCUS AS THE SCHOOL DEAN?
We have a significant population of extremely committed
individuals who have been here for a long time, and a time of
retirements and transitions are coming up. This is a challenge for the
administrative team. Another is the changing education curriculum
related to the National Dental Board Examinations. A third challenge
faced by the clinical world is shifting paradigms in healthcare policy.
There are both internal and external forces at play in this. We’ll make
sure we keep the clinics humming and provide the students with
sufficient experiences to play in the sandbox — so to speak — of this
changing world.
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Battling Cancer

rom
F
Mark Reeves, MD, PhD
Director of the Loma Linda University Cancer Center

Cancer is a formidable opponent.
Its diagnosis can be frightening.
One of the most emotionally
challenging parts of my job — or for
any physician — is having to inform
a patient of such a diagnosis. It was
hard the first time I had to do it, and
it’s still hard.
It’s difficult because even
when patients end up doing well,
a physician knows this diagnosis
will be a life-changing experience
for the patient. They’ll have to go
to a doctor’s office many times, get
treatments — then, even after they go
through curative treatment, they may
need long-term follow-up. So when
I tell a patient that they have cancer,
I understand what it’s going to mean.
It’s a very sobering thing for me.
But it’s often also a very inspiring
thing. Most patients who receive
this diagnosis have to come face-toface with their mortality. However,
when a lot of people might be afraid

and not willing to face the problem,
patients usually take the approach
of: “Let’s do what needs to be done.”
They also often take a very altruistic
approach and ask things like, “What
can I do to help the next person who
has to go through this?” Many wish
to volunteer to enroll in a clinical
trial to help future patients do better.
Their altruism and their practical
approach to life-changing, sobering
circumstances are very inspiring
to me.
This is an exciting time for the
Loma Linda University Cancer
Center. We’re training the next
generation of cancer professionals,
translating scientific discoveries
into state-of-the-art cancer care and
moving toward a national designation
that would help us play a larger role
in fighting cancer.
In upcoming pages, you’ll learn
about our all-encompassing support
network, including prevention,
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psychosocial support, treatment
options, as well as how technology is
involved in the battle now more than
ever before.
Most important in the battle
against cancer is research. There are
more than 75 active clinical trials in
the Cancer Center, and more than
1,000 patients are enrolled in these
trials each year. In addition, the
Cancer Center’s approach to research
and its translation into clinical care is
being guided by a strategic pathway
toward the National Cancer Institute
designation as a Comprehensive
Cancer Center, which you’ll learn
more about at the end of this section.
You can also learn more
by visiting the Loma Linda
University Cancer Center website
at lluh.org/cancer-center.
Cancer is a formidable opponent,
and we’re committed to helping fight
the battle with you.

15

ANSWERS

within a drop of

Genetic testing available at the Loma Linda University
Cancer Center offers the best chance for prevention or early
detection in people with high-risk factors, such as a strong
family history of certain cancers.
The DNA in blood or saliva can reveal information
on dozens of genes, identifying genetic abnormalities
that raise cancer risk significantly more than the
general population’s. The Cancer Center utilizes
genetic testing, when appropriately indicated,
for certain cancer types including breast,
ovarian, uterine, prostate, colorectal
and pancreatic, all of which can run
in families.
This testing is truly a case
where knowledge equals
power, says Sharon Lum,
MD, medical director
of the Breast Health
Center at the
Cancer Center.
“These results
are actionable,” she
says. “They are
more actionable
than most
things we do
in medicine.”
For several
types of cancers,
the Cancer Center
can test both patients
already diagnosed
with the disease and
people identified at highrisk for harboring a cancer
gene. For the latter, the genetic
testing results may indicate the

16
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need for more frequent cancer screening than the general
population, or for preventive measures. Genetic testing can
also influence the treatment they receive to lessen the chance
of cancer recurring.
In the case of breast cancer, for example, which can strike
men as well as women, a patient with a BRCA1 or BRCA2
gene mutation is about five times more likely to have cancer
return a second time than a patient without the BRCA1 or
BRCA2 mutations.
Family members can also be positively impacted by the
discovery of genetic mutations, revealing whether they should
also be tested.
Lum chose to be tested herself, because her father carries
the BRCA1 genetic mutation, which increases risk for
ovarian, breast, prostate and pancreatic cancers. Fortunately,
the mutation was not passed on to her.
The technology for genetic testing has evolved rapidly
over the past few years, making it faster and more affordable.
Because it uses multigene testing panels, the Cancer Center
sometimes discovers that a patient has high risk for a
different type of cancer entirely than they were testing for.
“With a drop of blood, you can literally test for hundreds
of different things,” Lum says.
Though such testing is also now available directly to
consumers, Lum warns that these companies may not
meet the high standards of laboratories used by hospitals,
geneticists and physicians. Nor can such companies offer the
necessary medical follow-up support.
The Cancer Center recommends that individuals discuss
their possible cancer risks with a physician. A statement to
start the conversation can be simple, such as “I'd like to talk to
you about getting screened for cancer.”
When genetic testing is indicated, Lum says doing so
proves true a second adage beyond “Knowledge is power.”
Traceable to the 13th century, the 800-year-old wisdom says,
“An ounce of prevention is worth a pound of cure.”
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IMMUNE TO CANCER’S RETURN?
THE DAY COULD BE COMING

The body’s immune system can be stimulated to help destroy cancer cells

Treatment advances that harness the
patient’s own immune system to fight
cancer are allowing doctors at Loma Linda
University Cancer Center to help people
who couldn’t be saved even just a few
years ago.
Immunotherapy, which utilizes or
enhances various components of the patient’s
immune system to fight cancer, has created
a paradigm shift in cancer research and
treatment, says Mark Reeves, MD, PhD,
director of Loma Linda University Cancer
Center. Thanks to this approach, for the
first time in the history of cancer treatment,
therapies are being deployed and developed
that are “site agnostic” — meaning they can
treat any and all types of cancer.
As a result, fewer and fewer cancers will
be considered a death sentence.
In melanoma, this possibility is already
becoming reality; immunotherapy has raised
five-year survival rates for patients with a nonoperable recurrence from 10 percent or less
to 80 percent or above, says Frank Howard
IV, MD, PhD, who specializes at the Cancer
Center in melanoma and unusual tumors.
“Getting the immune system to fight
cancer has been the holy grail of cancer
therapy for decades,” Howard says. “It is
certainly gratifying to be able to help people I
couldn’t help before.”
What’s more, immunotherapy has
few unpleasant side effects, making it
more tolerable for weakened patients than
chemotherapy or radiation.
“Immune checkpoint therapy” is one of
two classes of immunotherapies the Cancer
Center is offering, with “antibody therapy”
being the second. The latter injects antibodies
specific to the cancer cells into the patient’s
blood that focus the immune system on
the cancer. Antibody therapy currently
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shows greatest results in lymphoma and
breast cancer.
Checkpoint therapy may actually make
patients immune to the return of their cancer,
similarly to how people only get chicken
pox once.
Cancer can be so deadly because it rapidly
mutates to outsmart treatment. One such
mutation destroys a normal cellular pathway
called “mismatch repair” that helps a cell heal
itself. Freely replicating in their mutated state,
the cancer cells produce abnormal proteins
that signal the immune system to back off.
But the cancer cells’ evolved inability
to become normal again also makes them
vulnerable to checkpoint inhibitors, which
are injected into cancer patients and call the
immune system back with deadly accuracy
against the faulty cells.
“In the future, we will not primarily plan
treatment based on location of the cancer’s
origin in the body,” Reeves says. “We will ask
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Frank Howard IV, MD, PhD, says
immunotherapy is helping raise
five-year survival rates for many
patients battling cancer.
whether a patient’s cancer has a defect in the
mismatch repair pathway.”
Already becoming mainline therapy
against cancers that previously lacked effective
treatment options, immune checkpoint
therapy shows promise not only with
melanoma, but also Hodgkin’s lymphoma,
lung cancer, some types of gastric and
esophageal cancers, and bladder cancer. It is
actually now approved for all cancers that have
a defective mismatch repair pathway.
Upcoming in cancer immunotherapy is
a combination of checkpoint therapy with
vaccines, which is currently in human trials. It
is hoped this double-edged sword will make
cancer cells highly visible to the immune
system while also magnifying the system’s
cancer-killing power.
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Resource Center Offers
Cancer Care to
Whole person care for patients battling
cancer includes crucial psychosocial support.
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mind
spirit
and

A unique resource center housed within Loma Linda
University Health offers a single location for patients to access
services and information designed to treat more than the
clinical and medical aspects of a cancer diagnosis.
The Stater Bros. Charities and Inland Women Fighting
Cancer Patient Resource Center advances Loma Linda
University Health’s mission to provide whole person care, not
just treat disease. Cancer patients are often overwhelmed with
anxiety as they go through testing and diagnosis. They’re also
flooded with information about their medical condition and
potential treatment paths.
“Our services provide focused support to the psychological,
social and spiritual aspects of our patients’ lives,” says Tamie
Vasquez, CLM, CLMC, coordinator for the Patient Resource
Center. “All of those pieces must come together for a patient
to return to total health. Our patients are not just here for a
diagnosis and treatment. We make sure the right services are
made available at the right time. That’s our passion.”
Each patient visiting the Cancer Center completes a distress
screening form. A nurse navigator reviews the answers and
can immediately refer that patient to a wide range of support
services that will enhance the clinical side of their care.
“We automatically reach out to someone who has a high
distress score,” says Gabriela Gutierrez, MS, MFTI, an associate
marriage and family therapist at the Loma Linda Universtiy
Cancer Resource Center. “Often our initial contact leads to
therapy or ongoing support.”
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Patient Resource Center Services
Counseling

Individual, couple, group and family counseling can help assist
in the adjustment to a life with cancer. All counselors have training
specific to oncology needs. “Our support groups provide a safe place
where patients can get help, when they can’t get it at home,” says
Tamie Vasquez, Patient Resource Center coordinator.

Nutritional Support

Monthly nutrition talks help cancer patients, family members
and the general public learn about how healthy nutrition relates to
cancer. “These are popular because the talks focus on eating and less
on cancer itself,” Vasquez says. Call 909-558-2262 for the schedule
and upcoming topics.

Cooking Demonstrations

These bimonthly 90-minute cooking classes are designed to
be interactive experiences. Knowledgeable chefs and dietitians
show how to prepare foods that reduce cancer risk, heart disease
and more. These are held in the Nichol Hall kitchen at the School
of Allied Health Professions. Schedule and topics are available
at 1-877-LLUMC-4U.

Support Groups

An ongoing Women’s Cancer Support Group provides
opportunities to learn about topics such as stress reduction,
symptom management, relaxation and lifestyle changes. Caregivers
are welcome to attend the biweekly sessions at the Loma Linda
University Behavioral Health Institute in Redlands.
Call 909-558-2262 for dates and times.

Exercise Classes

Exercises can help open a patient’s lymphatic system, reducing
the swelling caused by lymphedema. Patients and family members
enjoy the supportive environments. Open to all fitness levels, the
classes are held every Thursday at the Loma Linda Senior Center.
Call 909-558-2262 for more information.

Appearance Center

A free community wig bank is available to women whose
chemotherapy or radiation treatments cause hair loss. “This can be a
very emotional issue for women,” Vasquez says. “Hair loss is such a
visible sign of their cancer. We provide significant support to them
at these moments.”

Look Good, Feel Better Program

Patients can receive personal consultations with a skin-care
professional. Free make-overs and cosmetics are available.
Participants also learn how to keep contamination from their
makeup. This is in partnership with the American Cancer Society.
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Women’s Cancer Support Groups serve most of the
Patient Resource Center’s patients. Groups are tailored to
specific needs and are open to patients and caregivers.
One important avenue of therapy available at the center is
in “onco-sex therapy.”
“Cancer is increasingly becoming a chronic illness, not
an acute one,” Gutierrez says. “While the immediate medical
issues may be over, it changes a person, and it changes their
relationships. It’s important to explore what it looks like to be
in a relationship while having cancer.” Virtually every patient
has one conversation about this issue, with roughly 60 percent
receiving multiple sessions to address the issue.
Gutierrez points out there are societal stigmas about
illnesses, and it’s up to each patient to decide if they wish to
accept or reject the stigma. Women are accustomed to identify
parts of their body as equating with femininity and desirability.
“The number one question most women ask is ‘Who
would want me now?’” Gutierrez says. “‘Who wants someone
with cancer?’ I’ve had women call themselves Frankenstein’s
monster, feeling their bodies are completely unrecognizable.”
Gutierrez helps couples explore how cancer has affected
their intimate relationships and addresses body-image issues.
Couples explore how they connected with each other before
cancer and ways they can maintain their intimate connection
despite cancer.
“Women will say to me, ‘I feel lighter. I feel a weight has
been lifted. I feel there’s hope,’” Gutierrez says. “It’s a privilege
to help people move forward.”
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Loma Linda University Health’s faith-based approach
to health and healing adds an important component to the
Patient Resource Center’s work. Being able to incorporate a
spiritual approach is an intricate part of care — one that is
taboo in many secular institutions.
“In many places, therapists are afraid to initiate
conversations about God,” Gutierrez says. “They’ll wait until a
patient brings up religion. God’s voice is a powerful voice for a
person on this journey. I appreciate that this institution allows
us to explore the spiritual dimensions of care.”
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THE TRUTH BEHIND
CLINICAL TRIALS
DEBUNKING COMMON
MISCONCEPTIONS BY JANELLE RINGER
There is often confusion on the topic of cancer clinical trials. Thousands of clinical trials are conducted annually,
and along with them come nearly as many misconceptions.
Some people say patients are merely guinea pigs, or that half the patients enrolled are simply given sugar
pills. These are some of the many myths that cause some patients to pause, and sometimes back out of clinical
research trials, says Judy Chatigny, MSN, executive director of the Loma Linda University Cancer Center.
“Clinical trials are a great way for cancer patients to get the latest treatment, and at the same time help the
next generation of patients that will face a diagnosis of cancer,” she says.
The Cancer Center team addresses some common myths to reveal the truth behind clinical trials:

MYTH: Patients are treated like guinea pigs.
TRUTH: Before any new treatment is used with people in clinical
trials, researchers work for years to understand its effects on cancer
cells and animals in the lab. They also try to determine side effects
the treatment. Before a treatment is used on patients, it has a long
track record of excellent results based on careful study. The truth
is, guinea pigs are treated like guinea pigs, and patients are treated
like patients.
MYTH: Half the group will just get sugar pills.
TRUTH: Placebos (often found in the form of sugar pills) are rarely
used in cancer treatment clinical trials. If they are used, they are
typically given in addition to standard proven treatments. Most
cancer treatment trials are designed to determine if experimental
treatments can add benefits to existing proven treatments. Patients
are always told if the study includes use of a placebo.
MYTH: There’s no real benefit to the patient.
TRUTH: Patients are living longer from successful cancer
treatments that are the results of past clinical trials. By taking part
in a trial, patients may have access to a new treatment that is not
available to people outside the trial. Science and medicine are
always evolving. Treatments are adjusted and constantly improved.
Often, these more-effective treatments are included in clinical trials,
allowing participants to be among the first to benefit.

MYTH: Research studies are only for people with no
other options.
TRUTH: Research studies aren’t exclusively used for people who
have cancer, let alone those who have no other options. Prevention
trials and screening trials are also popular. These types of trials
can reduce the threat that patients with a high risk might present,
as well as find the disease early when it’s more treatable. In
addition, research studies often enroll patients to determine if new
treatments add anything to current proven treatments. All patients
in such a study get at least the current, proven treatments.
MYTH: Clinical trials are too dangerous.
TRUTH: There are federal rules in place to help ensure the safety
and ethics of clinical trials. In addition, the trial is subject to ongoing
monitoring by the institution, the institutional review board (IRB)
and the research teams.
MYTH: Patients will have to stop all other
medical treatments.
TRUTH: Many clinical trials include standard therapy as part of
the study, which may be testing an additional drug to see if the
combination is more effective.

Understanding the truth behind clinical trials can help both current and potential patients decide if a
clinical trial is a viable option for them. Clinical trials are an enormous weapon in the fight against cancer,
and they hold the power to prove whether a new treatment works better than current treatments.
To find out more about the clinical trials offered at Loma Linda University Cancer Center,
visit lluh.org/cancer-center/research.
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Treating A Child’s
A growing number of cancer treatments benefits
B Y E R I C G N E C KO W
patients, now and in the future
Treatment of childhood cancers can take many paths at Loma
Linda University Children’s Hospital, the only medical center of its
kind in California’s Inland Empire. Yet for families traveling as long
as four hours to visit, the treatment process often starts with a very
different — and distinctly non-medical — conversation.
One Of Anguish And Love.
“So often when anything happens to a child, parents at times
with blinding love think it’s their fault,” says Rishikesh Chavan, MD,
director of pediatric bone marrow transplant for the hospital. “It’s
very hard when you are sitting with the parents to explain, ‘Your child
has cancer, and here is the plan.’ The most important thing, I believe,
during that initial diagnostic talk is that we absolve them of their guilt.”
Serving patients from four inland California counties and Nevada,
from birth to age 25, Loma Linda University Children’s Hospital’s
childhood cancer program is one of the largest in the United States. As
part of the Children’s Oncology Group, an international consortium of
leading childhood cancer treatment and research centers, the hospital
is on the forefront of the latest clinical trials and other best practice
treatment protocols for all types of childhood cancers, says Albert
Kheradpour, MD, division chief of pediatric hematology and oncology.
Parents in the region considering treatment for their children
should know that Loma Linda University Children’s Hospital
aggressively treats the unique biology of childhood cancer. Physicians
and staff in addressing the family dynamics that play an important role
in the patient’s long-term success, Kheradpour says.

“We’re not only treating
children, we are treating the
family as a whole,” he says.
Part of the 343-bed children’s hospital, the Pediatric HematologyOncology/Stem Cell Transplant Unit — or Unit 4800 — is a 33-bed
facility designed specifically for inpatient treatment of children with
cancer. The nearby Pediatric Hematology Oncology outpatient clinic
has numerous physician exam rooms and the capability to do infusion
therapy for 13 patients simultaneously. It also has its own pharmacy
and basic lab.
22
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Many young patients begin treatment at Unit 4800 before
transitioning to regular visits at the outpatient clinic, which sees
around 700 patient visits each month.
Both facilities feature an open floorplan that allows patients and
siblings to interact and socialize when possible over the course of
treatment. Child life specialists focus on keeping young patients and
their siblings engaged and entertained, and both locations have a social
worker on site.
The goal is to create a comfortable space for families, where many
treatment and lab services are available in one location, says Richard
Chinnock, MD, chief medical officer for Loma Linda University
Children’s Hospital.
“It’s an interesting question of how to best offer treatment for
children,” Chinnock says. “Do you create many separate rooms, which
is more the adult method of treatment, or a more open area so kids
can play with each other? We’re trying to support the whole child, the
whole family.”
The children’s hospital treats all types of childhood cancer,
where methodologies follow the best-practice protocols from the
Children’s Oncology Group. Among the latest available treatments are
immunotherapy trials using antibodies to target a child’s cancer cells.
Kheradpour describes this approach as one of today’s most promising
routes of pioneering childhood cancer treatment.
About 30 percent of children with cancer under the age of
15 suffer either leukemia or lymphoma — cancers of the blood
originating in the bone marrow or lymph nodes — forming the
most common group of childhood cancers, Chavan says. A smaller
proportion are patients with brain tumors or other solid tumors.
Allogenic bone marrow transplant, where the child’s bone marrow
is replaced with stem cells from a different donor, is required in more
difficult cases of leukemia or lymphoma; whereas autologous bone
marrow transplant allows surgeons to harvest and save the child’s own
bone marrow to be transplanted
after high-dose chemotherapy as a
salvage mechanism for high-risk brain
tumor and solid tumor patients. Loma
Linda University Children’s Hospital
completed 24 pediatric bone marrow
transplants in 2017 and a total of 280
since 2007.
Infection is the greatest risk for
pediatric bone marrow transplant
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Difficult Diagnosis
cancer survivors may experience unique health issues such as hormonal
imbalances and fertility problems.
“It’s not just enough to cure childhood cancer. It’s to ensure they
survive well,” he says.
The collaborative nature of childhood cancer treatment has had a
marked impact on its success, and today, childhood leukemia carries a
90 percent recovery rate, Kheradpour says. Part of that success is the
result of collaborative research facilitated by sharing of data through
the Children’s Oncology Group.
“It’s not just to benefit your child, it’s to benefit thousands of other
children,” he says.
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patients, so patients are required to live near the hospital during
recovery. In the spirit of whole person care, the hospital helps facilitate
housing assistance when necessary, Chavan says.
Treating childhood cancer is different than that of adults —
children bounce back better from chemotherapy, for example. Yet
much energy and time from medical staff goes into reassuring families
as well, where children and young adults with growing independence
must grapple with the shift to a secluded lifestyle in recovery.
Chavan said Loma Linda University Children's Hospital focuses
on guiding young patients and their families through that transition,
and also seeks to follow their recovery into adulthood, where some
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SURGICAL
ONCOLOGIST offers

REALISTIC
HOPE
for stage IV
cancer patients

LOMA LINDA UNIVERSITY HEALTH PHYSICIAN IS ONE OF ONLY EIGHT IN
SOUTHERN CALIFORNIA TO OFFER LIFESAVING PSM PROCEDURE

A surgical oncologist at Loma Linda University Health
is one of only eight physicians in all of Southern California
qualified to offer a rare, and often lifesaving, procedure that
is changing the game for patients diagnosed with stage
IV cancer.
Maheswari “Magi” Senthil, MD, chief of surgical
oncology and director of the peritoneal surface malignancy
program, says peritoneal surface malignancy, or PSM,
designates cancer that has invaded the lining of the
abdominal cavity and metastasized to multiple organs.
“Very few hospitals in the United States offer realistic
hope to patients with this diagnosis,” Senthil says,
adding that it is often considered a death sentence since
conventional therapies rarely achieve success once cancer
reaches stage IV.
But thanks to the two-stage surgical procedure, that is
not the case for Senthil’s patients. In the first stage, called
cytoreductive surgery, the physician cuts, scrapes and ablates
tumors and cancer cells off the affected organs. In the
second — which is known as hyperthermic interperitoneal
chemotherapy, or HIPEC — the surgeon inserts catheters into
the abdominal cavity and delivers heated chemotherapy drugs
to attack the microscopic cancer cells.
Together, the two stages can take between 10 and 24
hours, and the surgeon is required to stand the entire time.
“It’s the mother of all operations,” she says.
Senthil’s medical odyssey began early in life. When she
was 5 years old, her grandfather would often ask what she
wanted to become when she grew up. The precocious child
had a ready answer: she wanted to be a neurosurgeon. “I
didn’t even know what it was,” Sentil admits, “but my mother
was a physician and I used to go with her to the hospital
a lot.”
24

Back in those days, regulations were not as strict in
Senthil’s hometown of Madurai, India, as they are today, and
she was allowed inside the operating room to observe her
mother perform surgery.
“When I was 15, I became her scrub tech,” she says. “It
was very convenient for her to have a scrub tech who lived at
home, especially when she got called into the hospital to do
surgery in the middle of the night. She just had to wake me
up and I was ready.”
Senthil received her MD degree from Madurai Kamaraj
University in 1998 and moved to Massachusetts for a year
of research at Boston Children’s Hospital. After that, she
completed a seven-year surgery residency at the University
of Medicine and Dentistry of New Jersey and a two-year
surgical oncology fellowship at City of Hope in Duarte,
California. She learned the cytoreductive surgical procedure
during her nine years of surgical training. While at City of
Hope, she met Carlos Garberoglio, MD, chief of surgical
services at Loma Linda University Medical Center, who
invited her to start the peritoneal surface malignancy program
she now heads at Loma Linda University Health.
Despite the rarity of the procedure, Senthil has performed
it over 100 times since arriving at Loma Linda University
Medical Center in 2010. She is proud of her work.
“We have spectacular results at Loma Linda,” she
reports. “Instead of dying in a very short time, our patients
are often able to recover their health and live for many
more years.”
Read how a chance encounter on an airplane
led Dr. Senthil to save the life of a man last year.
Visit news.llu.edu/joseph-harouni.
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RIGHT PLACE, RIGHT TIME
FOR RESEARCHER EXAMINING LEUKEMIA’S HIGH RATE IN HISPANIC CHILDREN
Founder of business incubator company Elf Zone is advancing research from lab to clinic
BY KIMBERLY PAYNE, PHD, CEO OF ELF ZONE, INC. AND
DIRECTOR OF TRANSLATIONAL RESEARCH AT LOMA LINDA
UNIVERSITY SCHOOL OF MEDICINE AND CANCER CENTER
Sometimes we like to
imagine that the most important
things in life come with a plan,
but for me, it wasn’t that way.
When I first came to Loma
Linda University in 2006, I felt
guilty because I didn’t have some
grand plan, to be honest. But I
think God had a plan.
I was studying the normal
process by which our bodies
make B-lymphocytes, a type of
white blood cell. This particular
research had drawn me in for
various reasons, and over the
years I studied what can go
wrong in the development of
B-lymphocytes, which leads
to B-cell acute lymphoblastic
leukemia, also known as B-ALL.
It’s one of the most common
childhood malignancies.
Though I was doing research
at the Center for Health
Disparities and Molecular
Medicine at Loma Linda
University Health, I couldn’t
help but ask the question: how
can I help patients in the area I
was studying?
I was studying the pathways
used by cytokines, a type of
growth factor, and the role
they play in normal B-cell
development. It had been a
year since I started at Loma
Linda University when the

first data came back linking
a DNA-binding protein
that I was studying to B-cell
leukemia. Three years later,
the signaling pathway I was
studying in normal cells was
linked to three things: mutation
of that DNA-binding protein,
Hispanic children, and high-risk
B-cell lymphoblastic leukemia.
One by one the things I had
been studying were linked to
the disease.
Most B-ALL is curable —
about 90 percent. The other
10 percent is what’s most
critical. More children die of
B-ALL than any other cancer,
and it disproportionately
targets Hispanic children with
Native American ancestry — a
common patient base at Loma
Linda University Children’s
Hospital.
It was all coming together. I
was at a place where the patients
had the greatest need, combined
with my studies of the two
mutations critical for the highest
risk B-ALL. Where I was and
what I was studying gave me the
perfect position to begin looking
at therapies.
Surprisingly, we found that
a molecule required to produce
leukemia killed the leukemia
cells when they were given high
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levels of it, while also helping
normal immune cells to grow.
Once I had an idea of how
it was working, I contacted
Michael Samardzija, PhD,
JD, associate vice president for
research affairs at Loma Linda
University Health. He had
arrived just at the right time in
early 2016 and helped me start
Elf Zone Inc., a company in
the new business incubator he
started for the university.
Within six months, we were
awarded a small-business grant
from the National Institutes of
Health. The goal right now is
to work both through Elf Zone
and the studies in our research
laboratories to move the biologic
molecule forward as a drug. This
particular molecule both kills
the leukemia cells and also helps
normal B-cells recover and come
back stronger, according to our
data.
With any innovation, it
takes the whole world. In this
case, it took a team of people
from 11 countries who helped
work on the various studies.
The good thing is, Loma Linda
University Health is a smaller
institution than some, but we
have the infrastructure to make
things happen.
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We will continue
experiments to move the
molecule forward as a treatment
and try to understand more
about the mechanisms for how
the molecule functions. If we
understand how it works, we
can modify it to work better and
learn what other drugs work
best in combination for the
treatment of B-ALL.
Science has always fascinated
me. In fact, I was interested
in medicine at first simply
because I had never been around
scientists before. I grew up in
a small town of only 1,000
people called Rising Star, Texas.
Prior to pursuing my PhD in
microbiology and immunology
from the University of
Oklahoma Health Sciences
Center, I taught both high
school and community college
for eight years.
There’s this idea that
people will be doing exactly
the same thing for 30 years,
but I don’t think that’s the
model anymore. I like to
think I’m doing something
different — I’m moving toward
directly impacting people
through science.
—As told to Genesis Gonzalez
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Cancer researcher and team

LOOKING FOR THE
‘OFF’ SWITCH

To turn off a cell’s
switching mechanism

BY A N S E L O L I V E R
focused on understanding how cancer
and embryonic development relate.
One strategy she and her team
are targeting is using a protein that
has been found to turn DNA on
and off. Called Snail, it’s one of the
approximately 2,600 transcription
factors of the human genome that
can control how genes are activated.
This transcription factor causes a
process called epithelial-mesenchymal
transition, or EMT — which takes
place in embryonic development but
is never supposed to happen again.
In cancer cells, Snail triggers this
dormant process and causes them
to become migratory and act like
stem cells.
A tumor that stays in the organ is
obviously unhealthy, but it can turn
deadly once its cells travel to another
part of the body, known as metastasis.
Unternaehrer and her lab team
have implanted ovarian tumors into
mice, and the plan is to inject the
mice with nano-particles loaded
with ribonucleic acid molecules that
can turn off Snail. If this targeting is
found to work in mice, then the team
could eventually prepare for clinical
trials in humans.
She and teammate Yevgeniya Ioffe,
MD, received a $75,000 grant from
the school earlier this year to study
this process. They hope eliminating a
patient’s cancer stem cells could stop
tumors in their tracks.
“I would love to help patients
have a few more good years of life,”
Unternaehrer says.
PHOTO BY TANYA MUSGRAVE

A stem cell is a primitive cell that
is able to develop into a specific cell at
the embryonic stage — perhaps skin,
muscle or blood. But once the change
is made, that switching mechanism is
supposed to shut off.
Julia Unternaehrer, PhD,
assistant professor of basic sciences
at Loma Linda University School of
Medicine, is working to find out why
a cell’s switching mechanism can turn
back on to become cancerous. Once
a cell is a cancer stem cell, it can build
a tumor.
The challenging part of
treatment, Unternaehrer says, is that
cancer stem cells are more resistant
to cancer drugs than any other
cancer cells. Often when a patient’s
cancer goes into remission, cancer
stem cells can remain and
later reproduce.
Unternaehrer, a former
physical therapist who earned
a PhD in cell biology at Yale
University and worked
as a research fellow
at Harvard Medical
School, joined Loma
Linda University
Health in 2013. Her
research career has
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PROMPTING
LEUKEMIA
CELLS TO DIE

Researcher trying to
find a cure for disease
that took his mother
PHOTO BY ANSEL OLIVER

B Y E R I C G N E C KO W

Huynh Cao, MD, saw firsthand the
side effects of chemotherapy after doctors
diagnosed his mother with breast cancer in
1995. The treatment was difficult enough on
her body, Cao says, yet he also credits it for
causing her subsequent acute leukemia that,
despite a bone marrow transplant and further
chemotherapy, claimed her life in 2010.
The experience pointed Cao toward
what he called his “life’s work” at Loma Linda
University Health — developing a low-impact
and effective treatment for acute leukemia that
lacks the side effects of current options.
“My family went through the whole
thing, from A to Z,” says Cao, who became an
assistant professor at the School of Medicine
after completing a four-year hematology and
oncology fellowship in 2017. “I just hope we
can find something more tolerable,” he says.
Cao and his team are investigating how
vitamin D can prompt deadly leukemia cells
to mature — and die off — like the body’s
normal cells. Unlike normal cells with a finite
lifespan, cancer cells are effectively “immortal,”
Cao says, potentially growing unchecked to
cause diseases like acute leukemia.
His method involves a gene that converts
inactive vitamin D to an active form. Cao says
he uses stem cells to carry this gene to the
bone marrow.

The modified cell activates surrounding
vitamin D, which prompts the nearby
leukemia cells to mature. No longer immortal,
the leukemia cells then resume a normal
lifespan and die off, he says.
If taken orally, high doses of vitamin D
would be dangerous for a patient, Cao says.
The laboratory research shows promise that
the modified cells activating vitamin D would
limit their effect to the area of treatment
before dying off on their own.
Cao draws a parallel with a similar
leukemia treatment involving vitamin A.
Doctors once considered one particular
subtype of leukemia, acute myeloid leukemia
(AML) sub-type M3, extremely dangerous
until researchers discovered vitamin A could
prompt those types of cancer cells to mature
and die. Today, AML sub-type M3 is one
of the most treatable versions of the disease,
he says.
But Cao says treatment doesn’t work on
all subtypes of the leukemia, a cancer with
many variations that impact bone marrow
and blood. His vitamin D research could
reveal a way to treat other parts of the
leukemia spectrum.
He says the inspiration for his current
work followed the research of Loma Linda
University Health’s Distinguished Professor of
VOL. 53, NO. 2
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Medicine and Basic Sciences David Baylink,
MD, who discovered promise in treating
inflammatory bowel disease with vitamin D.
“My question was — why can’t we use the
same thing to treat leukemia?” he recalls.
Originally from Vietnam, Cao attended
UCLA’s Geffen School of Medicine before
working as a resident surgeon and completing
a subsequent internal medicine residency.
He came to Loma Linda University Health
in 2014.
In recognition of the potential of his
research, Cao was one of 66 researchers
nationally to receive $50,000 in grant funding
as part of the Conquer Cancer Foundation’s
Young Investigator Award in 2017. He says
he’s looking to obtain additional funding for
further research.
Cao’s work is currently focused in the
lab, using blood from leukemia patients and
involving experiments with mice. Though
it’s unknown when a possible treatment
could be tested in human subjects, he says
he’s optimistic about progressing toward his
ultimate goal.
“I want to find a cure for acute myeloid
leukemia,” he says.
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THE

NUTRITIONIST

IS IN

ANDREW WOODWARD’S
CANCER FIGHTING SUPER FOODS
SHORT LIST
Tips to consider: Since there is no “perfect
food” that has all the cancer fighting benefits,
include a variety of at least 5-9 servings of foods
from this list daily. Choose organic foods when
possible. Use whole foods rather than extracts
or supplements. These foods can be prepared as
juiced, eaten raw or lightly cooked. The amounts
to use can be suggested by a LLU Cancer Center
registered dietitian. Be aware that certain foods
may need to be avoided or limited, if allergy,
intolerances or drug interactions exist.
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LYCOPENE AND
CAROTENOID FOODS:
Acorn squash
Apricots
Beets
Bell peppers — yellow, orange or red
Carrots
Mangos
Nectarines
Papaya
Plums
Pumpkin (and other yellow squash)
Tomatoes (cooked is preferred)
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CRUCIFEROUS VEGETABLES:
Bok choy
Broccoli
Broccoli sprouts
Brussels sprouts
Cabbage and purple cabbage
Cauliflower
Kale
Turnips
GARLIC/DIALLYL
SULFIDE VEGETABLES:
Garlic
Leeks
Onions and Spanish purple onions
Shallots

Battling Cancer
ANDREW
WOODWARD
HELPS PATIENTS
BATTLING CANCER
FIND OPTIMUM,
CUSTOMIZED
NUTRITION
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BY A N S E L O L I V E R

BEANS/LEGUMES/SOY:
Black beans
Garbanzo beans (chickpeas)
Kidney beans
Lentils
Pinto beans
Soy* beans, tofu, soy milk,
soy nuts
Other beans and legumes
*Soy is safe for women
with breast cancer,
but high intake of soy
foods may interfere with
thyroid medications.

Patients battling cancer can struggle
to maintain weight when undergoing
infusion therapy or because of other
life stresses. Many attempt to educate
themselves about nutrition on the
internet, where they find information
that is often contradictory, outdated
or marketing.
Enter Andrew Woodward, MS, RD,
CSO, Loma Linda University Health’s
nutritionist for the Cancer Center,
who helps patients with a nutritionintervention strategy.
“I love enhancing a patient’s quality of
life and helping them get more enjoyment
with eating,” he says.
Woodward meets with more than 600
new patients each year, as well as many
more returning patients. He also offers
monthly cooking classes on health foods
that can battle or help prevent cancer. “We
go into the biochemistry of why certain
substances in foods fight cancer,” he says.
He enjoys traveling, and he brings
his international experience with
cultures, cuisine and seasonings into his
presentations and individual counseling
sessions based on a patient’s culture, diet
preference or locale.
Woodward’s biggest job is often
dealing with misinformation. “The
internet can do a lot of damage,” he says.
Patients might start avoiding all carbs

WHOLE GRAINS:
Barley
Brown rice
Bulgur
Corn
Oats and oatmeal
(steel cuts preferred)
Quinoa
Sweet potatoes/yams and
purple potatoes
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BERRIES:
Blackberries
Blueberries
Boysenberries
Cherries
Cranberries
Pomegranate
Raspberries
Strawberries
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and all sugars, then have a poor appetite,
lose weight and develop malnutrition. “I
acknowledge their fears and concerns and
put together a plan specifically for them,”
he says.
His top tip is to eat a plant-based
diet. He also helps infusion patients
strategically use healthy snacks to
maintain weight.
Woodward, a board certified oncology
nutritionist, first had his interest piqued
by Loma Linda University Health as
a high school student. He remembers
coming to the campus on a field trip
in 1972 and eating vegetarian food in
the cafeteria.
He went on to work in clinical
pathology at City of Hope, located in
Duarte, about an hour’s drive west of
Loma Linda, and later earned a master’s
degree in nutrition at California State
University, Los Angeles. He then worked
at Kaiser Permanente before joining Loma
Linda University Cancer Center in 2009.
Woodward says he was intrigued by
the organization’s vegetarian approach and
its pioneering studies on nutrition. Now
he’s a key part of helping patients nourish
themselves through their treatment.
“I see the value of early intervention,”
he says. “It’s encouraging to see patients
who have a serious diagnosis receive a plan
for nutrition direction.”

SEASONINGS:
Basil
Dill
Garlic
Ginger
Oregano
Parsley
Rosemary
Thyme
Tumeric
These are commonly
used, but others are
beneficial, too.

HEALTHY OILS:
Almond oil
Canola oil (rapeseed oil)
Extra virgin olive oil
Flax oil
Grape seed oil
Walnut oil
OTHER:
Apples
Asparagus
Citrus fruits
Melons
Mushrooms
Spinach

31

How a team of cancer researchers

FIND ANSWERS
and
NEW
TREATMENTS
from the California Cancer Registry database
John W. Morgan directs Regions 4, 5, 7 and 10
of the California Cancer Registry
One of the world’s most
sophisticated research tools is
helping cancer researchers at
Loma Linda University Health
discover new cancer treatments
and resources.
John W. Morgan, DrPH,
professor of epidemiology at
Loma Linda University School
of Public Health, and principal
investigator for Regions 4,
5, 7 and 10 of the California
Cancer Registry (CCR), says
the $100-million database
provides detailed information
about the more than 4.5 million
cancer cases diagnosed among
California residents since 1988.
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Without the CCR database,
cancer researchers at Loma
Linda University Health might
have access to only a few dozen
cases of certain rare cancers. But
with the database — which is
conveniently housed within the
Loma Linda University Cancer
Center — researchers can plug
into more than 10,000 cases.
“Without that rich database,
a lot of questions would be
unanswerable,” Morgan says.
“We do population-based
research. We have access to a
huge resource.”
The database allows Morgan
and his team of physicians,
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specialty fellows, faculty
members and doctoral students
from Loma Linda University
School of Public Health to
evaluate predictors of improved
survival in cancer patients after
diagnosis. He says the goal is
to comb through the data to
identify best-treatment practices.
“The big emphasis here is that
our research is multi-disciplinary
and translational,” he says.
Those terms reveal a lot
about the goals of the team.
Multi-disciplinary means the
team includes various health
specialties — such as surgical
oncologists, medical oncologists,
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epidemiologists, biostatisticians,
cancer registrars and data
analysts — to attack cancer
problems from several angles
and viewpoints. Translational
indicates that once researchers
find answers to particular
questions, they publish their
findings in respected cancer
journals so clinicians and other
health researchers can apply
best-practice prevention and
treatment practices.
Sometimes the findings
are surprising, especially when
they contradict widely held
assumptions. Morgan cites
beliefs about race and ethnicity

Battling Cancer
and ethnicity as predictors of
colorectal cancer. Risk is more
socioeconomically based than
racially based.”
The team also researches
breast, lung and stomach cancer.
By evaluating differences in the
behavior of cancers originating
from the right and left sides
of the colon, Morgan and his
team can predict how it will
respond to biologic therapy
once it spreads to the liver. This
provides opportunity to deliver
best-treatment practices to
specific patients.
“This previously
undiscovered finding
underscores the need for
improved screening and
treatment for the second
leading cause of cancer death
among Americans and holds
potential for increasing survival
for hundreds and thousands

of colorectal cancer patients
around the world,” Morgan says.
In addition to this
research, Morgan is the
principal investigator for a
long-term contract with the
National Cancer Institute.
The $4-million study, funded
since 1995, involves cancer
assessments in hundreds
of California communities.
Morgan’s finding that cancer
occurrence in Hinkley,
California — the city made
famous by the movie Erin
Brockovich — was similar to
the average risk in the wider
population. It resulted in
Hinkley’s removal from the
Centers for Disease Control
and Prevention’s list of cancer
clusters in the United States.
California’s diverse
population makes it an excellent
resource for cancer research.
“We can identify unique risks
predicted by that diversity,”
Morgan says. Although
California is not a high-risk
state for cancer, things are even
better in Loma Linda and
Redlands where socioeconomic

factors yield fewer tobaccorelated and preventable cancers.
Morgan says clinicians bring
the questions to the research
team, he brings the database
and epidemiology methods,
and graduate students bring
the sophisticated statistical
analysis skills.
“Without the medical
specialists asking the relevant
questions, the team wouldn’t
be translational,” he says,
adding that the Loma Linda
University School of Public
Health doctoral students
are the best data analysts
available. Together, the team
has published approximately
40 papers in scientific journals
in the last eight years, some of
which have changed the practice
of medicine, Morgan says. He
predicts the team will publish
many more, with three already
published or accepted for
publication during 2018.
That, of course, is good
news for patients who will
benefit from new insights
and treatments these studies
will uncover.
PHOTO BY ANSEL OLIVER

as examples. He points out that
for many years, clinicians and
researchers believed Black and
Hispanic males were more likely
to develop colorectal cancer
than White males.
But when Morgan and his
team — which includes breast
oncologist Sharon Lum, MD,
surgical oncologist Maheswari
Senthil, MD, chief surgeon
Carlos Garberoglio, MD, and
Cancer Center Director Mark
Reeves, MD, PhD — analyzed
the data, their findings refuted
this assumption.
“We found that as a group,
Black and Hispanic males
who are well-educated and
live in wealthy neighborhoods
are no more likely to get, or
die from, colorectal cancer
than a group of White men
having the same socioeconomic
status,” Morgan says. “We have
changed the thinking about race

VOL. 53, NO. 2

SCOPE

SUMMER 2018

33

USING
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Battling Cancer

NOLOGY
TO MAP ADHERENCE TO

CANCER SCREENINGS
Public health researcher wants to know why some
veterans don’t use non-invasive home test
BY JA M E S P O N D E R

Seth Wiafe, PhD, MPH, is director of
health geoinformatics at Loma Linda
University School of Public Health.

A Loma Linda University School of Public
Health researcher is trying to find out why some
U.S. military veterans are reluctant to use a
popular test for colorectal cancer.
The fecal immunochemical test, or FIT,
is faster and more convenient than the other
colorectal screening test, the colonoscopy, yet is
often shunned by veterans.
Unlike a colonoscopy, which must be
administered by a physician while the patient
is sedated, FIT involves no pain and does not
require anything to be inserted into
the patient’s anal opening while the
patient is sedated. It is also far less
INYO
expensive and can be selfadministered at home.
Public health
experts foresee a day
when burgeoning
SAN BERNARDINO
demand will
overtake the
RIVERSIDE
supply of
gastroenterologists,
making FIT the only
sensible alternative.
Seth Wiafe, PhD, MPH, director of health
geoinformatics at Loma Linda University School
of Public Health, is analyzing data from more
than 17,000 patients of the VA Loma Linda
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Healthcare System to find out why U.S. military
veterans from some zip codes, but not others, are
less likely to comply with their doctor’s orders to
take the FIT.
Preliminary findings reveal zip code pockets
within Inyo, Riverside and San Bernardino
counties where approximately half of veterans
do not complete the test. Wiafe uses Tapestry
Segmentation, a geographic information system
(GIS) developed by geomapping software firm
Esri, to search for commonalities among zip
codes where veterans do not support the test.
He says people should take colorectal cancer
seriously and cites an American Cancer Society
prediction that some 50,000 Americans will
die from the disease this year. Wiafe notes that
while colon cancer is the third most common
cancer, it has the second-highest mortality rate of
all cancers in this country. “Timely screening in
adults can significantly reduce the incidence and
mortality of colorectal cancer,” he says.
Wiafe is a pioneer in the use of GIS
technology. A native of the West African country
of Ghana, he hopes the data will yield a formula
for predicting whether veterans of any given zip
code are likely to take the test or not.
“If so, the Veterans Administration will need
to find out how they can increase adherence in
those areas,” Wiafe says.
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Loma Linda University Cancer Center
James M. Slater, MD
Proton Treatment & Research Center

The James M. Slater, MD Proton Treatment & Research
Center has treated more than 20,000 patients from 59
countries since it opened at Loma Linda University Health
in 1990. It was the world’s first hospital-based proton-beam
accelerator dedicated to the treatment of patients with
cancer. Here are some of the center’s major milestones.

1970

1970
1980

1987

1990

1990
1994

1997

2000

2000

2007

2010

2010

2014

2015
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2015

James M. Slater, MD, joins the Department of Radiology at Loma Linda
University; and it begins developing a dedicated section of radiation oncology.

Loma Linda University Medical Center and Fermilab
publish the engineering design report for the proton
synchrotron and beam transport system.

The first patient is treated at the Proton Treatment Center as
Loma Linda University Medical Center becomes the world’s
first hospital-based, treatment-dedicated proton center.
The second and third gantries begin clinical operation, and
construction of the cancer research laboratories begins.
Based on a presentation by Dr. Slater, research begins in the NASA-sponsored
Loma Linda University radiation medicine radiobiology laboratories.

reports that proton radiation therapy is one of the standard treatment options for prostate
cancer. This marks the first time that protons have received such mention in the popular press.

The Proton Treatment Center is renamed
after its founder, Dr. James M. Slater.

A robotic precision patient alignment system, which further improves
the accuracy of repeatable patient positioning, becomes operational.

Dr. David Bush and colleagues report excellent results from a five-year study on
cosmetic outcomes of partial breast radiation therapy with the proton beam.
The James M. Slater, MD Proton Treatment & Research Center celebrates its
25th anniversary. Today, it has treated more than 20,000 patients, more than
any other proton treatment facility in the world.
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Journey to

Battling Cancer

Comprehensive
Cancer Center

PHOTO BY ANSEL OLIVER

Designation from National Cancer
Institute would place Loma Linda
University Health in elite group

BY JUDY CHATIGNY, EXECUTIVE
DIRECTOR OF THE LOMA LINDA
UNIVERSITY CANCER CENTER

The Loma Linda University Cancer Center treats 45,000 patients each
year, many of whom have been told by other providers there was little
that could be done. Its approach of using teams of specialists employing a
combination of surgery, radiation and medication is able to offer hope and
healing to those most in need.
Now, the LLU Cancer Center is preparing for the next level in its ability
to serve patients and help offer groundbreaking research to professionals
worldwide. Loma Linda University Health is currently taking steps to earn a
designation from the National Cancer Institute to become a Comprehensive
Cancer Center, a move that would place the organization in an elite
fraternity of institutions around the country working to defeat cancer.
The designation would create a powerhouse discovery engine for
research, as well as give the Cancer Center an even larger translational
capacity to send that research to the clinic. The designation would make it
one of only 50 cancer centers in the United States to hold “comprehensive”
status by the National Cancer Institute.
Comprehensive Cancer Centers are uniquely situated to develop
specific treatments and medications for specific cancers, often cancers that
are prominent in a center’s home region. They also operate in a catchmentarea system, similar to regional trauma centers. When the Loma Linda
University Cancer Center earns “comprehensive” status, its catchment area
will be massive, and it will work to target the region’s unique disparities.
Other Comprehensive Cancer Centers in California are nearer to the coast.
To the east of Loma Linda, the closest one is a 430-mile drive to Tucson,
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Arizona. To the Northeast, the closest is a 650-mile drive to Salt Lake
City, Utah.
We’re looking to lead in helping solve problems that are unique to
our region.
It will be several years before Loma Linda University Health officials
present their formal submission. But steps are being put in place now, and
the Cancer Center is aggressively recruiting for this new direction. In the
meantime, here are ways in which supporters can help:
• Financially support the Cancer Center’s research.
• If you have cancer or know someone who does, enrollment in a
clinical trial moves medical professionals closer to a cure.
• Encourage friends to do screening for cancer, either through selfexamination or through an appointment with a doctor.
• Volunteer at the Loma Linda University Cancer Center.
• Participate in community cancer awareness events, such as the
Believe Walk in Redlands, held the first Sunday each October, or the
Celebration of Life, the first Sunday each June.
Thank you for your support as the Loma Linda University Cancer
Center moves toward the nation’s most prestigious honor for an oncology
institution, and more importantly, will contribute in an even greater way to
the battle against cancer.
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A VISION COMING INTO FOCUS
V I S I O N 2 0 2 0 – T H E C A M PA I G N F O R A W H O L E
TOMORROW IS TRANSFORMING LIVES
T H R O U G H I N N O VAT I V E E D U C AT I O N
Vision 2020 is a $360-million comprehensive
philanthropic initiative, the largest in the history of Loma
Linda University Health. The effort also represents the
largest investment in healthcare and education in the
Inland Empire.
A key part of Vision 2020 is to ensure Loma Linda
University remains a special place where students aspire
to study and learn about our unique brand of healthcare.
One priority is affordability, helping put this valuable
education within reach for the most promising and
mission-minded future healthcare workers.
Representatives from Loma Linda University School
of Nursing recently received a call from a person acting
as trustee for an estate. The trustee shared a story of
how the estate holder was so impressed with the warm,
professional care that Loma Linda University Medical
Center nurses had provided more than 40 years ago
that she wanted to contribute support for future nurses.
The trustee indicated that there would be a gift of $1
million coming to the School of Nursing. When school
representatives went to meet with the trustee to learn
more of the story, they received news of a second estate
gift of $500,000, making a total bequest of $1.5 million.
Each year, 16-24 nursing students will benefit from this
endowment. This generous act has resulted in a nearly
12 percent increase in scholarship funds available for
School of Nursing students.
Since Vision 2020 was launched, people with
abundant hearts for students have established more
than 20 new scholarship endowment funds. In addition,
donors have contributed to more than 100 scholarship
funds that started before Vision 2020 began. These gifts
provide vital financial support for students in need.
“Education is the best thing you can give a person,”
Loma Linda University alumnus Don Hall said. And over
the years many people have benefited from Hall’s belief
in education. After earning a Doctor of Public Health in
Preventive Care, Hall’s career led him 40 years ago to
launch Wellsource, a company offering computerized
health analysis programs. Corporations use these
programs to help their employees better understand and
improve their health.
38

Hall is continually exploring ways to have the most
impact on helping people live healthy lives. Seeing the
potential to shine a light on the Adventist Health Study,
Hall and his wife, Trish, decided to fund an endowed
chair for the School of Public Health — the Don and
Trish Hall Research Professorship. These funds will be
significant in supporting the important Adventist Health
Study, the long-term series of research projects exploring
the benefits of lifestyle and diet on disease among
Seventh-day Adventists.
The Hall professorship is one of eight new endowed
chairs/professorships established since the beginning
of Vision 2020. In addition, more than 20 existing
chairs/professorships have been expanded during
Vision 2020. These professorships and chairs generate
earnings from endowments, and it’s those earnings that
support a professor’s compensation, scholarship and
responsibilities in teaching, research and service.
Loma Linda University is dedicated to continuing
our growing research emphasis. Throughout its history,
university-based researchers have asked questions that
were daring, difficult and ahead of their time: Could we
save a newborn’s life with a transplanted heart? Could
a beam of protons destroy cancer without damaging
surrounding tissue? Is there a way to keep dental
patients conscious yet comfortable during procedures?
The world is waiting for answers to new questions
that Loma Linda University Health is uniquely positioned
to answer.
Earlier this year, the Vision 2020 effort passed a
significant milestone when it was announced that less
than $100 million of the $360 million goal was left to
be raised.
“We are so grateful to all who have supported the
campaign,” said Rachelle Bussell, MA, CFRE, senior vice
president for advancement. “Our community friends and
university alumni who believe in our mission to continue
the teaching and healing ministry of Jesus Christ have
played key roles in helping us reach this point. But we
know that we still have much work to do.”
For more information, visit lluhvision2020.org.
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MOVING ON UP
VISION 2020 IS A $360-MILLION
P H I L A N T H R O P I C C A M PA I G N S U P P O R T I N G
L O M A L I N D A U N I V E R S I T Y H E A LT H ’ S
COMPREHENSIVE VISION FOR THE
FUTURE THROUGH FOUR PRIORITY AREAS:
E D U C AT I O N , C L I N I C A L C A R E , R E S E A R C H
AND WHOLENESS.
The construction of a new Medical
Center and new Children’s Hospital tower
are the most visible aspects of the Vision
2020 campaign.
The foundational pedestals were put in
place last summer — all 126 of them. Each
one was designed and built to support a
new 16-story Medical Center and nine-story
addition to Children’s Hospital at Loma Linda
University Health. Now, Loma Linda’s skyline
is undergoing a dramatic, permanent change
with the construction of the steel frames.
There’s an urgency to completing these
new facilities. The State of California has
mandated stringent seismic safety regulations
for acute-care hospital buildings, which
must meet these new standards by the year
2020. Facilities that have not met the new
requirements face closure. Confronting what
seemed to be a monumental challenge, Loma
Linda University Health stepped forward
in faith, placing the new hospitals as a
cornerstone of Vision 2020.
After considering various options to move
forward, Loma Linda University Health leaders
concluded that retrofitting the institution’s
iconic cloverleaf tower, in use since 1967,
would not be the best approach. Instead,
constructing a new Medical Center and
expansion of the Children’s Hospital was more
financially responsible. New construction
also meant an opportunity to rethink how
healthcare is delivered in a hospital setting
40

in the 21st century and create a model for
the future.
The 126 pedestals play a key role in
meeting the new state seismic requirements.
The entire array will operate as “friction
pendulum isolators,” designed to slide up to 84
inches horizontally under the hospital structure
during an earthquake without the building
itself moving. Special springs to absorb
vertical movement may also be added, which
would make this the first hospital building
in the world to implement such earthquakemitigation measures and set a new standard in
seismic safety.
The pedestal system serving as the base
of the new hospital is the first of its kind, said
Kerry Heinrich, JD, chief executive officer of
Loma Linda University Medical Center. “These
pedestals represent the leading technology in
the world, and they will make a real difference
in the seismic safety of the new hospital.”
Each pedestal is 10-1/2 feet wide, 10-1/2
feet long, and 3-1/2 feet tall, with each one
weighing 10 tons. The units were built in
Eloy, Arizona, and trucked to Loma Linda for
placement. Each pedestal took about three
weeks to assemble.
While seismic safety is the primary
consideration in the pedestal design, these 126
units will be the platform for a hospital facility
that incorporates the latest advances in patient
care and comfort. The new building also
supports expansion of key adult services, such
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as the Level 1 trauma center, the Emergency
Department, the International Heart Institute
and nearly doubles the size of the Neonatal
Intensive Care Unit.
“There is no question this new building
will be the foundation of another significant
expansion of the Loma Linda University
Health story,” said Richard H. Hart, MD, DrPH,
president of Loma Linda University Health. “But
the building itself only supports the people
and events that happen inside. Students will
learn new skills, residents will perfect their
specialties, faculty will push the boundaries
of science and thousands of patients will be
blessed with a special kind of care.”
Loma Linda University Health’s mission
statement commits the organization and its
people to continue the teaching and healing

PHOTO BY ANSEL OLIVER

ministry of Jesus Christ. The new hospital facilities
are central to fulfilling many healing objectives.
But it’s the mission statement’s teaching emphasis
that is a large part of why the hospital exists at
all. The organization’s hospitals are the primary
teaching laboratory for the thousands of students
studying here in medicine, nursing, allied health
professions, pharmacy, behavioral health specialties
and chaplaincy.

PHOTO BY JANELLE RINGER

Learn more at lluhvision2020.org.

Kerry Heinrich, JD, right, CEO of Loma Linda
University Medical Center, and Eric Schilt,
assistant vice president for construction,
during a recent tour of the construction site
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Gallery

2018
7

1. The Loma Linda University Church Orchestra and Choir
perform during Sabbath worship, which was held in the
Drayson Center.
2. Participants of the Sabbath morning Parade of Flags wore native
dress from their home countries or countries where they served
as missionaries.
3. Attendees were treated to a haystack lunch following the Sabbath
church service.
4, 5, 6. Numerous alumni performed in a talent show on
Saturday night.
7. A 5K fun run was held Sunday morning, with proceeds
supporting scholarships for the schools of Nursing and Pharmacy.
8. School of Allied Health Professions Dean Craig Jackson, JD,
MSW, right, formally participated in the Sunday pickleball
tournament along with School of Public Health Dean Helon
Hopp Marshak.
9. Homecoming was a great chance to catch up with friends.
42
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Loma Linda in the World

S A C R A M E N T O ,

C A L I F O R N I A

SCHOOL OF MEDICINE ALUMNUS
B R A Y L E Y I S P H Y S I C I A N F O R N B A’ S
SACRAMENTO KINGS
By ARIN GENCER

When Jason Brayley, MD, applied
to become chief of sports medicine for
Kaiser Permanente in Sacramento, he
was drawn to the healthcare system’s
vision for growing its sports medicine
practice and its approach to keeping
people healthy.
He didn’t give much thought, if
any, to talk of Kaiser Permanente
potentially becoming the primary
medical provider for the California
capital city’s Sacramento Kings.
But about a month after the
Yucaipa, Calif., native started his new
job, his boss asked what he would
think about being a Kings’ team doctor.
Brayley is now one of two
physicians who regularly attend home
games, responsible for the care of
the Kings and of the visiting team,
referees and other staff. If a medical
issue arises before, during or after a
game, Brayley is available to attend to
the matter as needed.
He also acts as the Kings’ primary
care doctor, advising and treating
players and their families when they
have medical needs — whether
it’s dealing with the flu, stomach
ailments, infections or other issues.
“It’s a 24/7 job,” Brayley says.
“NBA athletes are human beings just
like us with families and life stresses.
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Part of my job has been to establish
relationships that help provide care
in any way that the athlete or family
may need.”
Brayley also enjoys providing the
same level of care to the range of
patients who walk through the doors
of Kaiser’s sports medicine center
inside Golden 1 Center, the Kings’
home arena.
Brayley’s role is one he never
imagined for himself, though he
can pinpoint experiences that, in
retrospect, clearly helped set the
stage. One is his time in medical
school: he especially credits two
professors — Resa Chase, MD, and
Ben Nava, PhD — for encouraging
him to persevere despite a trying
first quarter.
He also points to the sacrifices of
his family to support his education.
His father was a psychiatric tech who
worked two full-time jobs, and his
mom taught second-grade. Brayley
didn’t come from a line of doctors, but
growing up near Loma Linda, he was
surrounded by them. An early interest
in physical therapy while in high
school at Loma Linda Academy evolved
into a desire to pursue medicine.
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“It was a career that was
interesting, that I thought was a good
calling, so I went for it,” he says.
He attended Pacific Union College
in Northern California’s Napa Valley
before going on to Loma Linda
University School of Medicine in
1997. He grew interested in family
medicine as he completed rotations
at military hospitals, which were
required for the U.S. Navy scholarship
that paid for his last three years of
medical school. After graduating
in 2001, he completed a three-year
family medicine residency through the
Naval Hospital Camp Pendleton on the
Marine Corps base north of San Diego,
followed by three years of service at
Naval Air Weapons Station China Lake
in the western Mojave Desert.
A sports medicine fellowship
at Ohio’s Cleveland Clinic — the
healthcare provider for the Cleveland
Cavaliers — began laying the
groundwork for his future practice.
Working under team doctors for a
year gave him an up-close view of the
rhythms and requirements of being
an NBA physician. At the same time,
he volunteered as doctor for a cycling
team, a role he performed until 2013,
further expanding his experience in
caring for professional athletes.
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“The fellowship leaders
thought it was a good idea for
me to get my feet wet, so they
supported me doing that on
my own,” says Brayley, who
had long followed professional
cycling and done his share of
road racing. “Being involved
with a domestic professional
cycling team was a great
opportunity to expand taking
care of athletes.”
After his fellowship,
Brayley looked for jobs with
a sports-medicine focus that

also would bring him back
to California. An opportunity
with a Seattle-area healthcare
system came first, and he and
his young family headed west.
Five years later, the position
in Sacramento opened, and he
jumped at the chance to work
in Northern California.
In some ways, he’s come
full circle: The Kings played
in the first NBA game he
ever attended.
“I look back in hindsight
and realize how many of these
VOL. 53, NO. 2

little small things that seemed
relatively unimportant at the
time were part of the bigger
picture,” Brayley says.
“Every move I’ve made
since high school and college
is based on leaps of faith, and
you feel like you’re sort of
steered in one direction,” he
says. “My wife and I felt like
we’ve been led every step of
the way.”
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Jason Brayley before a game in
March. He typically arrives to
games 90 minutes before tip off.
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Loma Linda in the World

S I L V E R

S P R I N G ,

M A R Y L A N D

T H E E M E R G E N C Y P R E PA R E R
School of Public Health alumna coordinates
international support when tragedy strikes

The complexity of humanitarian work hit
Canadian Elizabeth Tomenko as a new college
graduate when she worked at a homeless shelter
in the Downtown Eastside — a neighborhood
in Vancouver, British Columbia, notorious
for poverty, drug addicts, prostitutes and
criminal runaways.
She worked in the kitchen and loved helping
people eat healthy, but reality hit hard.
“We would put a salad before someone off
the street, but they couldn’t eat it because they
had no teeth. It was then I learned that health
was a lot more complicated than telling someone
to eat their veggies,” Tomenko says.
Since then, she’s gone on to work in the
complex world of international humanitarian
service, coordinating food and emergency support
for tens of thousands. The 2014 graduate of
Loma Linda University School of Public Health
now works at the home office for the Adventist
Development and Relief Agency (ADRA), which
is based at the Seventh-day Adventist Church’s
world headquarters in Silver Spring, Maryland.
Her role as the Emergency Response Program
Manager for Asia-Pacific and North America has
taken her all over the globe and brought her faceto-face with numerous humanitarian crises.
Last year, her job at ADRA took her to the
sprawling Rohingya refugee camps in Bangladesh.
Hundreds of thousands of Rohingya, a stateless
Muslim minority, have fled their homes in
Myanmar because of violent persecution and are
stuck in makeshift camps in a country that can
ill-afford to help.
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“It was debilitatingly heartbreaking,” she
says about what she saw in the camps. “It’s
extremely motivating to be there, but at the same
time, you have to somewhat distance yourself
from the people you are trying to help to be able
to function.”
What was striking, she says, was just 40
minutes away from the nearest camp was a resort
town filled with tourists having a great time.
“Vacationers were jet-skiing when, just down
the road, I was in a camp filled with desperate,
fearful, hungry families.”
She has helped coordinate responses
to numerous massive emergency situations
— everything from flooding in Nepal and
Bangladesh to typhoons and volcanic eruptions
in the Philippines to hurricanes and wildfires in
North America.
Tomenko first joined ADRA in 2014 as the
Adventist Church’s Ebola response coordinator,
a newly-created position at the time to help
several denominational entities respond to the
Ebola outbreak in West Africa. She had been with
World Vision when she learned ADRA needed
someone in a temporary slot to help with that
emergency. She got the job and, when the crisis
abated, ADRA hired her permanently.
When not in the field, Tomenko spends most
of her time in the office, remotely coordinating
and providing support to humanitarian activities
across her region. “I’m on the phone and Skype a
lot,” she says. “It’s not unheard of for me to be on
a call at midnight when it’s business hours on the
other side of the world.”
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By CLIFFORD GOLDSTEIN

more trips, even living and studying
in Thailand and teaching English in
Albania before earning a degree in food,
nutrition, and health science at the
University of British Columbia.
From there, Tomenko came to Loma
Linda University, where her love of
travel, interest in nutrition, and desire
to help others all coalesced when she
earned her Master of Public Health
degree in Global Health. Here, mentors
and teachers encouraged her, helping
her catch the vision that enabled her to
take all her passions to their potential.
In the Integrated Community
Development course, she spent part
of a summer with several hands-on
community health projects in Peru.

She says the school provided great
mentorship and opportunities to be
involved and connected to church-based
health systems and initiatives around
the world.
“I wouldn’t have gotten that
networking or those opportunities
anywhere else,” she says.
For now, she’s watching out for
other potential emergencies, monitoring
a cyclone, a tropical storm and two
volcanoes at once, and keeping in
close contact with ADRA’s teams on
the ground.
“In this world, you never know what
is going to come next,” she says. “We
need to be ready for anything.”
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Her support comes in the form of
proposal writing and review, seeking
and coordinating pooled funding for
responses, and training country office
staff. When necessary, she helps deploy
extra teams to support emergency
responses. Sometimes that means she
goes herself.
“I had less than 12 hours’ notice
before deploying to Bangladesh for
the Rohingya refugee crisis,” she says.
“I had been planning a different trip
but was advised to change it at the
last minute.”
Tomenko’s interest in working
internationally was piqued in high
school when she went on a mission trip
to Belize. Later, she went on several
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Parting Shot

GOING TWICE
Auctioneer Jim Nye, left, works the audience at the 25th
Anniversary Children’s Hospital Foundation Gala at the Riverside
Convention Center in March to sell a painting by Jeff Hanson, right, a
visually impaired philanthropic artist.
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The painting sold for $24,000 — twice, with Hanson offering to
paint a replica for a second bidder. Hanson then auctioned off his tie
and cummerbund, which sold for $1,000.
The event raised $2.36 million for Loma Linda University
Children’s Hospital services.
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Yolanda and Dennis De La Paz
Revocable Living Trust with Charitable
Remainder Clause

Powerful
Strategies
FOR PEOPLE WHO CARE
Retired banking VPs Yolanda and Dennis had their financial future covered.
Once Dennis was diagnosed with prostate cancer, the family searched for
stability and healing at Loma Linda University Heath (LLUH).
Given a second chance at life, the De La Paz’s were inspired to give back to
LLUH through Planned Giving.
Their strategy was to include a charitable remainder clause in their
revocable living trust.
Let us help you discover your Powerful Strategy.

LLUHMKTG#221-ADV-18/0618/1

Office of Planned Giving
11175 Mountain View Avenue, Suite B, Loma Linda, CA 92354
909-558-4553 | legacy@llu.edu | llulegacy.org
To read more about Dennis and Yolanda’s story, visit llulegacy.org/ps.
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What is Your
Reason to
get a Cancer
Screening?
Encourage each other to know your cancer risk by visiting

LomaLindaCancerQuiz.org. Loma Linda University Cancer Center
has the latest screening technology for the early detection of breast
and prostate cancer. We are the leading cancer center in the region,
offering comprehensive care from diagnosis to survivorship. Cancer is
not a choice. Choose to get a screening today.
We LIVE for early detection of breast and prostate cancer.

For more information, visit LomaLindaCancerQuiz.org.
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